Filing Flows › Precision Biosciences (DTIL) › Stock forecast & fair value
Precision Biosciences (DTIL) stock forecast and price target
Precision Biosciences (DTIL) trades at $10.60. 5 analysts' median price target is $20.00 (+89%), from $18.00 to $60.00.
Precision Biosciences' latest quarter
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DTIL stock?
The median of 5 analysts' 12-month targets is $20.00, +89% from $10.60; the range is $18.00 to $60.00. The average rating is none.
Does Precision Biosciences usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is DTIL stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.